0001209191-21-004324.txt : 20210120
0001209191-21-004324.hdr.sgml : 20210120
20210120163824
ACCESSION NUMBER: 0001209191-21-004324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210115
FILED AS OF DATE: 20210120
DATE AS OF CHANGE: 20210120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoppenot Herve
CENTRAL INDEX KEY: 0001596492
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 21539221
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION-EXPERIMENTAL STN.
STREET 2: ROUTE 141 & HENRY CLAY RD., BLDG. E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-15
0
0000879169
INCYTE CORP
INCY
0001596492
Hoppenot Herve
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
1
1
0
1
Chairman / CEO
President
Employee Stock Option (right to buy)
90.56
2021-01-15
4
A
0
74720
0.00
A
2031-01-14
Common Stock
74720
74720
D
Beginning January 15, 2021, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2021 and the remainder vesting monthly over three years.
/s/ Herve Hoppenot
2021-01-20